The Palmitoylation of the N-terminal Extracellular Cys37 Mediates the Nuclear Translocation of VPAC1 Contributing to Its Anti-apoptotic Activity

Overview

Journal Oncotarget

Specialty Oncology

Date 2017 May 6

PMID 28473666

Citations 10

Authors

Rongjie Yu

Hongyu Liu

Xinhe Peng

Yue Cui

Suqin Song

Like Wang

Huahua Zhang

An Hong

Tianhong Zhou

Affiliations

Soon will be listed here.

Abstract

VPAC1 is class B G protein-coupled receptors (GPCR) shared by pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP). The first cysteine (Cys37) in the N-terminal extracellular domain of mature VPAC1 is a free Cys not involved in the formation of conserved intramolecular disulfide bonds. In order to investigate the biological role of this Cys37 in VPAC1, the wild-type VPAC1 and Cys37/Ala mutant (VPAC1-C37/A) were expressed stably as fusion proteins with enhanced yellow fluorescent protein (EYFP) respectively in Chinese hamster ovary (CHO) cells. Both VPAC1-EYFP and VPAC1-C37/A-EYFP trafficked to the plasma membrane normally, and CHO cells expressing VPAC1-EYFP displayed higher anti-apoptotic activity against camptothecin (CPT) induced apoptosis than the cells expressing VPAC1-C37/A-EYFP, while VPAC1-C37/A-CHO cells showed higher proliferative activity than VPAC1-CHO cells. Confocal microscopic analysis, western blotting and fluorescence quantification assay showed VPAC1-EYFP displayed significant nuclear translocation while VPAC1-C37/A-EYFP did not transfer into nucleus under the stimulation of VIP (0.1 nM). Acyl-biotin exchange assay and click chemistry-based palmitoylation assay confirmed for the first time the palmitoylation of Cys37, which has been predicted by bioinformatics analysis. And the palmitoylation inhibitor 2-bromopalmitate significantly inhibited the nuclear translocation of VPAC1-EYFP and its anti-apoptotic activity synchronously. These results indicated the palmitoylation of the Cys37 in the N-terminal extracellular domain of VPAC1 mediates the nuclear translocation of VPAC1 contributing to its anti-apoptotic activity. These findings reveal for the first time the lipidation-mediating nuclear translocation of VPAC1 produces a novel anti-apoptotic signal pathway, which may help to promote new drug development strategy targeting VPAC1.

Citing Articles

PACAP regulates VPAC1 expression, inflammatory processes and lipid homeostasis in M1- and M2-macrophages.

Witzel R, Block A, Pollmann S, Oetzel L, Fleck F, Bonaterra G Front Cardiovasc Med. 2023; 10:1264901.

PMID: 37900572 PMC: 10611464. DOI: 10.3389/fcvm.2023.1264901.

Identification of substrates of palmitoyl protein thioesterase 1 highlights roles of depalmitoylation in disulfide bond formation and synaptic function.

Gorenberg E, Tieze S, Yucel B, Zhao H, Chou V, Wirak G PLoS Biol. 2022; 20(3):e3001590.

PMID: 35358180 PMC: 9004782. DOI: 10.1371/journal.pbio.3001590.

Human CD4CD45RA T Cells Behavior after In Vitro Activation: Modulatory Role of Vasoactive Intestinal Peptide.

Villanueva-Romero R, Cabrera-Martin A, Alvarez-Corrales E, Carrion M, Perez-Garcia S, Lamana A Int J Mol Sci. 2022; 23(4).

PMID: 35216459 PMC: 8878027. DOI: 10.3390/ijms23042346.

Identification and Expression Analysis of G Protein-Coupled Receptors in the Miridae Insect .

Gao H, Li Y, Wang M, Song X, Tang J, Feng F Front Endocrinol (Lausanne). 2021; 12:773669.

PMID: 34899608 PMC: 8660763. DOI: 10.3389/fendo.2021.773669.

VIP Modulation of Hippocampal Synaptic Plasticity: A Role for VIP Receptors as Therapeutic Targets in Cognitive Decline and Mesial Temporal Lobe Epilepsy.

Cunha-Reis D, Caulino-Rocha A Front Cell Neurosci. 2020; 14:153.

PMID: 32595454 PMC: 7303298. DOI: 10.3389/fncel.2020.00153.

References

Karacay B, ODorisio M, Kasow K, Hollenback C, Krahe R . Expression and fine mapping of murine vasoactive intestinal peptide receptor 1. J Mol Neurosci. 2002; 17(3):311-24. DOI: 10.1385/JMN:17:3:311. View

Coleman D, Gray A, Kridel S, Cardelli J . Palmitoylation regulates the intracellular trafficking and stability of c-Met. Oncotarget. 2016; 7(22):32664-77. PMC: 5078042. DOI: 10.18632/oncotarget.8706. View

Rosenbaum D, Rasmussen S, Kobilka B . The structure and function of G-protein-coupled receptors. Nature. 2009; 459(7245):356-63. PMC: 3967846. DOI: 10.1038/nature08144. View

Gobeil F, Fortier A, Zhu T, Bossolasco M, Leduc M, Grandbois M . G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can J Physiol Pharmacol. 2006; 84(3-4):287-97. DOI: 10.1139/y05-127. View

Valdehita A, Carmena M, Bajo A, Prieto J . RNA interference-directed silencing of VPAC1 receptor inhibits VIP effects on both EGFR and HER2 transactivation and VEGF secretion in human breast cancer cells. Mol Cell Endocrinol. 2011; 348(1):241-6. DOI: 10.1016/j.mce.2011.08.031. View

Couvineau A, Darmoul D, Maoret J, Carrero I, Ogier-Denis E, Laburthe M . Human intestinal VIP receptor: cloning and functional expression of two cDNA encoding proteins with different N-terminal domains. Biochem Biophys Res Commun. 1994; 200(2):769-76. DOI: 10.1006/bbrc.1994.1517. View

Chaumet A, Wright G, Seet S, Tham K, Gounko N, Bard F . Nuclear envelope-associated endosomes deliver surface proteins to the nucleus. Nat Commun. 2015; 6:8218. PMC: 4579783. DOI: 10.1038/ncomms9218. View

Jiang X, Benovic J, Wedegaertner P . Plasma membrane and nuclear localization of G protein coupled receptor kinase 6A. Mol Biol Cell. 2007; 18(8):2960-9. PMC: 1949383. DOI: 10.1091/mbc.e07-01-0013. View

Barbarin A, Seite P, Godet J, Bensalma S, Muller J, Chadeneau C . Atypical nuclear localization of VIP receptors in glioma cell lines and patients. Biochem Biophys Res Commun. 2014; 454(4):524-30. DOI: 10.1016/j.bbrc.2014.10.113. View

10.

Gahbauer S, Bockmann R . Membrane-Mediated Oligomerization of G Protein Coupled Receptors and Its Implications for GPCR Function. Front Physiol. 2016; 7:494. PMC: 5078798. DOI: 10.3389/fphys.2016.00494. View

11.

Yu R, Guo X, Zhong J, Li M, Zeng Z, Zhang H . The N-terminal HSDCIF motif is required for cell surface trafficking and dimerization of family B G protein coupled receptor PAC1. PLoS One. 2013; 7(12):e51811. PMC: 3528735. DOI: 10.1371/journal.pone.0051811. View

12.

Bkaily G, Al-Khoury J, Jacques D . Nuclear membranes GPCRs: implication in cardiovascular health and diseases. Curr Vasc Pharmacol. 2014; 12(2):215-22. DOI: 10.2174/1570161112666140226120837. View

13.

Reubi J, Laderach U, Waser B, Gebbers J, Robberecht P, Laissue J . Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res. 2000; 60(11):3105-12. View

14.

Liu S, Zeng Y, Li Y, Guo W, Liu J, Ouyang N . VPAC1 overexpression is associated with poor differentiation in colon cancer. Tumour Biol. 2014; 35(7):6397-404. DOI: 10.1007/s13277-014-1852-x. View

15.

Estrada R, Wang L, Jala V, Lee J, Lin C, Gray R . Ligand-induced nuclear translocation of S1P(1) receptors mediates Cyr61 and CTGF transcription in endothelial cells. Histochem Cell Biol. 2008; 131(2):239-49. PMC: 2861785. DOI: 10.1007/s00418-008-0521-9. View

16.

Seoane I, Ortiz A, Piris L, Lamana A, Juarranz Y, Garcia-Vicuna R . Clinical Relevance of VPAC1 Receptor Expression in Early Arthritis: Association with IL-6 and Disease Activity. PLoS One. 2016; 11(2):e0149141. PMC: 4755558. DOI: 10.1371/journal.pone.0149141. View

17.

Valdehita A, Bajo A, Fernandez-Martinez A, Arenas M, Vacas E, Valenzuela P . Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Peptides. 2010; 31(11):2035-45. DOI: 10.1016/j.peptides.2010.07.024. View

18.

Omary M, Kagnoff M . Identification of nuclear receptors for VIP on a human colonic adenocarcinoma cell line. Science. 1987; 238(4833):1578-81. DOI: 10.1126/science.2825352. View

19.

Gaudin P, Couvineau A, Maoret J, Laburthe M . Mutational analysis of cysteine residues within the extracellular domains of the human vasoactive intestinal peptide (VIP) 1 receptor identifies seven mutants that are defective in VIP binding. Biochem Biophys Res Commun. 1995; 211(3):901-8. DOI: 10.1006/bbrc.1995.1897. View

20.

Drenan R, Doupnik C, Boyle M, Muglia L, Huettner J, Linder M . Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family. J Cell Biol. 2005; 169(4):623-33. PMC: 2171691. DOI: 10.1083/jcb.200502007. View